0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      New Light Shed On The Enigmatic Eosinophil Granulocyte; A Versatile Cell Of The Immune System.

      review-article
      , *
      EJIFCC
      The Communications and Publications Division (CPD) of the IFCC

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Eosinophils normally constitute only a few per cent of circulating leukocytes, though they are more numerous in tissues vulnerable to attack by environmental microorganisms. Eosinophils can kill invasive parasites, but they also have immunoregulatory functions and may be involved in, for example, the connective tissue remodeling that occurs in conjunction with inflammation. Although their effects may be beneficial to the host, for instance in the event of helminthic infestation, they may also cause tissue damage, for example in allergy and asthma. Recent years have witnessed significant advances in our knowledge of these fascinating but still enigmatic cells.

          The eosinophil granulocyte was first described in 1879 by Paul Ehrlich, who discovered a blood cell that had high affinity for acid dyes and, in particular, eosin ( 1) ( Figure 1). Eosin, which gives the cells their characteristic red-orange color, is named after Eos, the goddess of dawn in Greek mythology. Paul Ehrlich also put forward the hypothesis that eosinophils develop in the bone marrow ( 2) and exert their functions in the peripheral tissues.

          All vertebrates seem to have eosinophils in their blood, but these cells have also been described in more primitive organisms such as sharks, turtles and snakes ( 3). However. there are differences in morphology, and a comparison of eosinophils from different species also reveals considerable differences in the protein content of their characteristic cytoplasmic granules. For example, in contrast to many vertebrates, eosinophils from the cat, rhino, hyena and okapi lack peroxidase ( 3).

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Interleukin-5, eosinophils, and disease.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The idiopathic hypereosinophilic syndrome.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

              In the mid-1980s, Mosmann, Coffman, and their colleagues discovered that murine CD4+ helper T-cell clones could be distinguished by the cytokines they synthesized. The isolation of human Th1 and Th2 clones by Romagnani and coworkers in the early 1990s has led to a large number of reports on the effects of Th1 and Th2 on the human immune system. More recently, cells other than CD4+ T cells, including CD8+ T cells, monocytes, NK cells, B cells, eosinophils, mast cells, basophils, and other cells, have been shown to be capable of producing "Th1" and "Th2" cytokines. In this review, we examine the literature on human diseases, using the nomenclature of type 1 (Th1-like) and type 2 (Th2-like) cytokines, which includes all cell types producing these cytokines rather than only CD4+ T cells. Type 1 cytokines include interleukin-2 (IL-2), gamma interferon, IL-12 and tumor necrosis factor beta, while type 2 cytokines include IL-4, IL-5, IL-6, IL-10, and IL-13. In general, type 1 cytokines favor the development of a strong cellular immune response whereas type 2 cytokines favor a strong humoral immune response. Some of these type 1 and type 2 cytokines are cross-regulatory. For example, gamma interferon and IL-12 decrease the levels of type 2 cytokines whereas IL-4 and IL-10 decrease the levels of type 1 cytokines. We use this cytokine perspective to examine human diseases including infections due to viruses, bacteria, parasites, and fungi, as well as selected neoplastic, atopic, rheumatologic, autoimmune, and idiopathic-inflammatory conditions. Clinically, type 1 cytokine-predominant responses should be suspected in any delayed-type hypersensitivity-like granulomatous reactions and in infections with intracellular pathogens, whereas conditions involving hypergammaglobulinemia, increased immunoglobulin E levels, and/or eosinophilia are suggestive of type 2 cytokine-predominant conditions. If this immunologic concept is relevant to human diseases, the potential exists for novel cytokine-based therapies and novel cytokine-directed preventive vaccines for such diseases.
                Bookmark

                Author and article information

                Journal
                EJIFCC
                EJIFCC
                eJIFCC
                EJIFCC
                The Communications and Publications Division (CPD) of the IFCC
                1650-3414
                29 May 1999
                May 1999
                : 11
                : 1
                : 6-25
                Affiliations
                [001]Departments of Internal Medicine
                [* ]Laboratory Medicine, Section for Clinical Chemistry, Lund University, University Hospital MAS , Malmö, Sweden
                Author notes
                Address correspondence to: Arne Egesten, M. D., Ph. D., Department of Medicine, University Hospital MAS, SE-205 02 Malmö, Sweden. Telephone: +464033 1571 Fax: +464033 6208 e-mail: Arne.Egesten@ 123456medforsk.mas.lu.se
                Article
                ejifcc-11-006
                6357243
                deba61ab-e849-45e4-b1df-cd13f91438bf
                Copyright © 1999 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 7, Tables: 2, Equations: 0, References: 31, Pages: 20
                Categories
                Review

                Comments

                Comment on this article